DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
Bromocriptine Mesylate is a drug marketed by Lek Pharm, Mylan, Zydus Pharms Usa Inc, Paddock Llc, and Sandoz Inc. and is included in six NDAs.
The generic ingredient in BROMOCRIPTINE MESYLATE is bromocriptine mesylate. There are nine drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the bromocriptine mesylate profile page.
A generic version of BROMOCRIPTINE MESYLATE was approved as bromocriptine mesylate by SANDOZ INC on January 13th, 1998.
Summary for BROMOCRIPTINE MESYLATE
|Finished Product Suppliers / Packagers:||6|
|Raw Ingredient (Bulk) Api Vendors:||71|
|Formulation / Manufacturing:||see details|
|Drug Prices:||Drug price information for BROMOCRIPTINE MESYLATE|
|What excipients (inactive ingredients) are in BROMOCRIPTINE MESYLATE?||BROMOCRIPTINE MESYLATE excipients list|
|DailyMed Link:||BROMOCRIPTINE MESYLATE at DailyMed|
Recent Clinical Trials for BROMOCRIPTINE MESYLATE
Identify potential brand extensions & 505(b)(2) entrants
|Mylan Pharmaceuticals||Phase 1|
Pharmacology for BROMOCRIPTINE MESYLATE
|Drug Class||Ergot Derivative |